Skip to main content
. 2019 Aug 1;7:2515135519862234. doi: 10.1177/2515135519862234

Figure 3.

Figure 3.

All cancer therapies can lead to in vivo vaccination events.

T-Vec, talimogene laherparepvec; PV-10, Rose Bengal pink dye; IL, interleukin; PD-1, programmed cell-death 1; CTLA, cytotoxic T-lymphocyte antibody; BCG, Bacillus Calmette–Guérin; DNCB, 2, 4-dinitrochlorobenzene; DNP, dinitrophenyl; DCPC, diphencyprone.